Linus Health Showcases AI Innovations at AAIC 2025
Linus Health will present its latest AI-driven digital solutions at the Alzheimer's Association International Conference (AAIC) 2025, held from July 27-31 in Toronto and virtually. Announced in a press release, the company will showcase two oral presentations and eight posters, highlighting advancements in early detection and personalized brain health care.
Linus Health's presentations will focus on AI-powered digital cognitive assessments, which aim to streamline clinical trial recruitment and enhance patient engagement. The company will also unveil new platform solutions that enable remote use by patients at home, aligning with its vision to provide proactive brain health support.
Key topics include the use of machine learning models to detect cognitive impairment and predict Alzheimer's disease pathology. The research underscores Linus Health's commitment to leveraging AI for earlier and more accurate detection of cognitive disorders, ultimately improving patient outcomes and clinical trial efficiency.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Taiwanese Health Technology Groups Test US Market in Dallas
ADLM to Brief Congress on Healthcare AI Policy
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi
Insilico Medicine Opens AI Longevity Research Toolkit
Daily AI Brief: the AI news that matters, in your inbox.